Sort
78,016 grants matching “breast cancer”
SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
$435,092University Of California Davis · U10 · FY2003 · CA
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
$435,054Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · NS
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
$435,054Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · NS
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
$435,054Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · NS
COUPLES DEALING WITH CANCER--ANALYSIS AND INTERVENTION
$435,051Fox Chase Cancer Center · R01 · FY2002 · CA
Development of Mechanism-Based Strategies for the Treatment of Advanced Breast Ca
$435,045Neal Rosen · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy
$435,007Elad Ziv · University Of California, San Francisco · P20 · FY2025 · CA
Synthetic Calibrators for Immunohistochemical Assays
$435,002Medical Discovery Partners, Llc · R44 · FY2004 · CA
Elucidating the structural basis of differential interactions of human BECN paralogs and their role in cellular homeostasis
$435,000Sangita Sinha · North Dakota State University · R15 · FY2017 · GM
CAPER, a New Regulator of DNA Damage and Repair in Triple Negative Breast Cancer
$434,998Isabelle Mercier · Saint Joseph'S University · R15 · FY2022 · CA
Impact of Allostatic Load and Neighborhood Contextual Factors on Breast Cancer in the Women's Health Initiative
$434,993Adana A. M. Llanos · Columbia University Health Sciences · R01 · FY2022 · CA
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
$434,990Bhuvaneswari Ramaswamy · Ohio State University · R01 · FY2022 · CA
Cancer and Leukemia Group B - The Ohio State University
$434,962Clara D Bloomfield · Ohio State University · U10 · FY2007 · CA
Administrative Core
$434,935William Nicholas Haining · Dana-Farber Cancer Inst · U2C · FY2018 · CA
Nanoparticle contrast agents for earlier breast cancer detection
$434,923David Peter Cormode · University Of Pennsylvania · R01 · FY2019 · CA
3H-pyrazolo[4,3-f]quinoline-containing compounds as selective and tunable protein kinase inhibitors
$434,910Herman O Sintim · Purdue University · R01 · FY2024 · CA
An engineered bacterial reporter gene fusion for radiotheranostics
$434,903Sarah Marie Cheal · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · CA
SYMPTOMS OF TRANSPLANT PATIENTS NEAR THE END OF LIFE
$434,885University Of Texas Md Anderson Can Ctr · R01 · FY2000 · CA
Administrative Core
$434,881Eliezer M Van Allen · Dana-Farber Cancer Inst · U2C · FY2022 · CA
Administrative Core
$434,881Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2019 · CA
Administrative Core
$434,879Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2020 · CA
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance
$434,780Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Targeting Dectin-2 on Tumor-associated Macrophages for the Treatment of Cancer
$434,773Edgar G. Engleman · Stanford University · R01 · FY2020 · CA
Targeting Dectin-2 on Tumor-associated Macrophages for the Treatment of Cancer
$434,773Edgar G. Engleman · Stanford University · R01 · FY2018 · CA
Targeting Dectin-2 on Tumor-associated Macrophages for the Treatment of Cancer
$434,773Edgar G. Engleman · Stanford University · R01 · FY2021 · CA